We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03360890
Brief Title: Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors (iPRIME)

First Submitted : November 20, 2017
First Submitted that Met QC Criteria : December 1, 2017
First Posted : December 4, 2017

Last Update Submitted that Met QC Criteria : February 14, 2023
Last Update Posted : February 16, 2023